- Bhagwani, Aneel R;
- Ali, Mehboob;
- Piper, Bryce;
- Liu, Mingjun;
- Hudson, Jaylen;
- Kelly, Neil;
- Bogamuwa, Srimathi;
- Yang, Hu;
- Londino, James D;
- Bednash, Joseph S;
- Farkas, Daniela;
- Mallampalli, Rama K;
- Nicolls, Mark R;
- Ryan, John J;
- Thompson, AA Roger;
- Chan, Stephen Y;
- Gomez, Delphine;
- Goncharova, Elena A;
- Farkas, Laszlo
Pulmonary arterial hypertension (PAH) features pathogenic and abnormal endothelial cells (ECs), and one potential origin is clonal selection. We studied the role of p53 and toll-like receptor 3 (TLR3) in clonal expansion and pulmonary hypertension (PH) via regulation of bone morphogenetic protein (BMPR2) signaling. ECs of PAH patients had reduced p53 expression. EC-specific p53 knockout exaggerated PH, and clonal expansion reduced p53 and TLR3 expression in rat lung CD117+ ECs. Reduced p53 degradation (Nutlin 3a) abolished clonal EC expansion, induced TLR3 and BMPR2, and ameliorated PH. Polyinosinic/polycytidylic acid [Poly(I:C)] increased BMPR2 signaling in ECs via enhanced binding of interferon regulatory factor-3 (IRF3) to the BMPR2 promoter and reduced PH in p53-/- mice but not in mice with impaired TLR3 downstream signaling. Our data show that a p53/TLR3/IRF3 axis regulates BMPR2 expression and signaling in ECs. This link can be exploited for therapy of PH.